← Back to headlines

Early data for heart drug affirm Lilly’s billion-dollar bet on Verve

This story is reported by BioPharma Dive. Read what other outlets are saying below, then open the original report for full details.

Early data for heart drug affirm Lilly’s billion-dollar bet on Verve · NabkaNews